Morey v. Mentor Corporation, No. 4:2011cv05065 - Document 168 (M.D. Ga. 2013)
Court Description: ORDER denying 165 Motion for Reconsideration; denying 165 Motion for Summary Judgment. Ordered by Judge Clay D. Land on 06/03/2013. (CGC)
Download PDF
<![CDATA[
IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF GEORGIA COLUMBUS DIVISION IN RE MENTOR CORP. OBTAPE * TRANSOBTURATOR SLING PRODUCTS * LIABILITY LITIGATION * MDL Docket No. 2004 4:08-MD-2004 (CDL) Case No. 4:11-cv-5065 (I. Morey) O R D E R At a final pretrial conference on May 31, 2013, the Court expressly found that Plaintiff could assert a continuing duty to warn claim under Minnesota law. Defendant has now filed a motion for reconsideration, or in the alternative, motion for summary judgment as to that claim (ECF No. 165 in 4:11-cv-5065). For the following reasons, that motion is denied. Plaintiff’s continuing duty to warn claim is actionable under Minnesota law, and therefore, evidence of substantially similar complaints made to Mentor after Plaintiff was implanted with ObTape is admissible in support of such a claim to show that Mentor had notice of the alleged risk of harm associated with ObTape. Defendant argues that Plaintiff has never asserted a continuing duty to warn claim in this case, and to allow her to do so now is inconsistent with the Federal Rules Procedure pleading requirements and just plain unfair. of Civil In the alternative, Defendant insists that a continuing duty to warn claim is not recognized in Minnesota under the circumstances presented in this case. Notwithstanding Defendant’s bold proclamation of reversible error, the Court finds that Defendant is simply wrong on both counts. First, Defendant’s attempt to manufacture an enumeration of error by feigning last minute surprise ignores the allegations in Plaintiff’s Complaint which clearly put Defendant on notice of a continuing duty to warn claim. the following: Those allegations include “Defendant negligently failed to provide such warning or instruction that a manufacturer exercising reasonable care would have provided to physicians who implanted the Mentor ObTape vaginal sling, or those women who had been implanted with Mentor ObTape vaginal sling. . . .” Compl. ¶ 14, ECF No. 1 in 4:11-cv-5065. “Before Plaintiff suffered the injuries complained of herein, Defendant was on notice of numerous bodily injuries caused by ObTape, and based thereon, Defendant knew or should have known that ObTape caused an unreasonably high rate of vaginal erosion, [etc.], in women implanted with said device, but unreasonably failed to take action with respect to said adverse consequences.” Id. ¶ 15. “. . . Defendant unreasonably failed to stop marketing the ObTape in the United States until in or around March of 2006.” Id. ¶ 16. “. . . Defendant unreasonably failed to provide adequate warnings or information to physicians who implanted the device, or to women who were implanted with the device, informing them that ObTape caused an 2 unreasonably high rate of vaginal erosion, infection, extrusion, perforation and/or abscess.” Id. ¶ 17. And perhaps the “clincher,” “Defendant breached their duty of reasonable care to Plaintiff by failing to promptly and adequately notify Plaintiff, Plaintiff’s doctors, the medical community, and the public at the earliest possible date of known defects in the Mentor ObTape vaginal sling.” Id. ¶ 24. It is clear that Plaintiff’s Complaint contained sufficient allegations to put Defendant claim. on notice of Plaintiff’s continuing duty to warn The next question is whether such a duty exists under Minnesota law. It is undisputed that a “continuing duty to warn claim” is recognized under Minnesota law, but it is not unlimited. The Minnesota Supreme Court has held that the “continuing duty to warn arises only in special cases.” Rubber Co., 426 N.W.2d 826, 833 Hodder v. Goodyear Tire & (Minn. 1988). The issue presented here is whether Plaintiff’s case is a “special case.” The Minnesota Supreme Court found the following factors relevant in determining whether a particular case is a “special case” such that a continuing duty to warn cause of action may be maintained: (1) whether the seller either knows or reasonably should know that the product poses a substantial risk of harm; (2) whether the product creates a serious risk of injury or death; (3) whether the seller remains in business, even if it no 3 longer sells the specific product in question; and (4) whether the seller undertook a duty to warn of the dangers presented by the product. Id. at 833. Defendant argues that the fourth factor not only weighs against a continuing duty to warn claim in this action, but that consideration of this factor alone mandates a finding that no such claim exists in this action as a matter of Minnesota law. The Court finds that this one factor is not, standing alone, dispositive of whether a continuing duty to warn claim may be asserted under Minnesota law. Defendant reads Hodder to hold that a continuing duty to warn claim can only be asserted under Minnesota law if the seller affirmatively undertook a duty to warn of the dangers presented by the product after the product was sold. Under this interpretation, only the conscientious seller, who voluntarily undertook a duty to warn of product dangers after sale, would expose itself to liability for failing to provide an adequate post-sale warning. To escape any liability on a continuing duty to warn claim, the seller merely has to avoid even attempting to warn of a Defendant’s product’s dangers argument, after the the sale. manufacturer who According to reasonably appreciates a clear danger, attempts to warn about it, but does so negligently would be subjected to potential liability; but a manufacturer faced with the same evidence of product dangers and who likewise appreciates a serious danger that should be warned 4 about, but liability. choses The to do Court nothing finds would nothing sanction such an absurd result. be in exposed Hodder to that no would Hodder does not emphasize this fourth factor, nor does it even suggest that it should be given a predominant place among the other factors. It certainly does not suggest that it is an essential element of a continuing duty to warn claim. The Court understands that it may be an essential element of a tort claim that is based on the general concept in tort law that while a person may have no legal duty to perform a particular act, when they do undertake to act, they must do so non-negligently. for continuing duty to warn. But that is not a cause of action The Court simply cannot find any indication that the Minnesota Supreme Court in Hodder intended to limit the continuing duty to warn to the narrow duty of providing a warning non-negligently once you have undertaken to warn. Although that may be an appropriate factor to consider, it is not dispositive. At least one United States District Court judge sitting in Minnesota has rejected Defendant’s interpretation of Hodder in a case remarkably similar to the present case. G.D. Searle district & judge Co., 707 F. concluded In Kociemba v. Supp. 1517 (D. Minn. 1989), that the manufacturer of the an intrauterine device could have a continuing duty to warn of known dangers associated with 5 the product even if the manufacturer had not undertaken a duty to warn after the sale of the device. That court inferred that the Minnesota Supreme Court’s reference to the manufacturer having undertook a duty to warn referred to warnings that pre-dated the sale. 29. Id. at 1528- While there was evidence in Hodder that the manufacturer had attempted to warn both pre-sale and post-sale, there is nothing in the holding to suggest that undertaking to warn postsale had any more legal significance than attempting to warn pre-sale. The significance would appear to be that the manufacturer was arguably aware of dangers that should have been warned about before the sale of the product and the manufacturer continued to accumulate information, putting it on notice that it should issue warnings post-sale. If the manufacturer acted negligently in failing to warn, then it could be found liable. Although observes it is that certainly the not binding Minnesota precedent, District Judges the Court Association Committee on Civil Jury Instructions Guides apparently thought the approach taken in the Restatement (Third) of Torts should be considered when evaluating a continuing duty to warn claim. elements for such a claim are quoted in the The “Authorities” section of the pattern jury instructions, suggesting that this committee of Minnesota judges considered the Restatement to be consistent with the law of Minnesota. Jury Instruction Guides – Civil § 75.40. 6 4A Minnesota Practice, The Restatement provides: (a) One engaged in the business of selling or otherwise distributing products is subject to liability for harm to persons . . . caused by the seller’s failure to provide a warning after the time of sale or distribution of a product when a reasonable person in the seller’s position would provide such a warning. (b) A reasonable person in the seller’s position would provide a warning after the time of sale if: (1) the seller knows or reasonably should know that the product poses a substantial risk of harm to persons or property; and (2) those to whom a warning might be provided can be identified and can reasonably be assumed to be unaware of the risk of harm; and (3) a warning can be effectively communicated to and acted on by those to whom a warning might be provided; and (4) the risk of harm is sufficiently great to justify the burden of providing a warning. Restatement (Third) of Torts: Products Liability § 10 (1997). In this case, Plaintiff contends that Mentor either knew or reasonably should have known that ObTape poses a substantial risk of creates harm a business; physicians to serious that women who risk of Mentor prior to were implanted injury; undertook to implantation with that Mentor warn women of ObTape; it; is that it still in through that their Plaintiff reasonably could have been identified as a woman who had been implanted with ObTape; that Plaintiff’s physician who implanted 7 Plaintiff’s ObTape reasonably could have been identified and located; that Plaintiff was otherwise unaware of the risk of harm associated with ObTape; that an effective warning reasonably could have been provided to Plaintiff’s implanting physician and acted upon resulting in avoidance of the harm; and that the burden of risk of harm providing the is sufficiently warning. The great to justify Court finds that the the current record is adequate to support a finding that this is a “special case” under Minnesota continuing duty to warn claim. law for the assertion of a 1 1 The Court finds that the cases cited by Defendant at the hearing either support the finding of the existence of a continuing duty to warn claim under the circumstances presented here, are distinguishable or are unpersuasive. See, e.g., McDaniel v. Bieffe USA, Inc., 35 F. Supp. 2d 735, 742 (D. Minn. 1999) (holding continuing duty to warn of dangers associated with bicycle helmets existed even in the absence of manufacturer’s attempt to warn post-sale and explaining that no one Hodder factor is determinative); see also Sanny v. Trek Bicycle Corp., Civil No. 11-2936 ADM/SER, 2013 WL 1912467, at *11 (D. Minn. 2013) (holding that the plaintiff failed to plead sufficient facts to state a claim for continuing duty to warn and explaining that insufficient evidence existed regarding several of the Hodder factors); Quist v. Sunbeam Products, Inc., Civil No. 08-5261 (DWF/AJB), 2010 WL 1665254, at *4-*5 (D. Minn. Apr. 22, 2010) (finding evidence insufficient to establish continuing duty to warn claim where, under the facts in the case, it would be unreasonable to expect manufacturer to trace every product that it sold and where there was no evidence that post-sale warnings would have prevented plaintiff’s injuries); Keller v. CNH America, LLC, Civil No. 07-1648 ADM/AJB, 2009 WL 1766695, at *7 (D. Minn. June 22, 2009)(finding no continuing duty to warn where manufacturer had not undertaken such duty and the plaintiff presented evidence of only two previous substantially similar incidents); Hammes v. Yamaha Motor Corp., Civil File No. 03-6456 (MJD/JSM), 2006 WL 1195907, at *13 (D. Minn. May 4, 2006)(dismissing post-sale duty to warn claim by noting that manufacturer never undertook a duty to warn of the risk in question but emphasizing that “[the] Hodder factors all turn on direct indifference to a known problem and to serious bodily injury,” which the Court did not find in Hammes) (emphasis added); Ramstad v. Lear Siegler Diversified Holdings Corp., 836 F. Supp. 1511, 8 The evidence Court at observes trial to that Plaintiff not support must the only still basis present for her continuing duty to warn claim but also the breach of that duty. If an adequate basis for the claim is shown, the Court will decide that a duty to warn exists and will submit the issue of whether it has been breached to the jury. claim, Plaintiff must also prove that To recover on the the breach caused her injuries. As to whether Defendant is entitled to judgment as a matter law of on Plaintiff’s continuing duty to warn claim because of lack of evidence, Defendant will have an opportunity to raise that issue in a motion for judgment as a matter of law at the close of Plaintiff’s case. The Court finds Defendant’s request for summary judgment untimely. Based on the Court’s ruling regarding Plaintiff’s continuing duty to warn claim, the Court finds that post-implant evidence of safety concerns associated with ObTape are admissible to show notice of the harm and need for additional post implant warnings. The Court also finds, however, that only evidence covering the period prior to the partial removal of Plaintiff’s ObTape on June 29, 2005 would be admissible. As of the date her physician surgically removed part of her ObTape due to her complications allegedly caused by the ObTape, Plaintiff 1517 (D. Minn. 1993) (holding that no continuing duty to warn claim existed when only factor favoring imposition of such duty was the gravity of the resulting harm.). 9 was aware of risk of harm associated with ObTape, and thus, Mentor’s duty to continue to warn would cease as of that date. Consequently, subsequent evidence of notice would be irrelevant.2 In conclusion, Defendant Mentor Worldwide LLC’s Motion for Reconsideration Or, In the Alternative, Motion for Summary Judgment (ECF No. 165) is denied. IT IS SO ORDERED, this 3rd day of June, 2013. S/Clay D. Land CLAY D. LAND UNITED STATES DISTRICT JUDGE 2 This does not mean that evidence subsequent to June 29, 2005 may not be admissible for some other purpose. For example, subsequent substantially similar incidents may be admissible to show causation, or subsequent evidence that ties directly to the period preceding June 29, 2005 may be admissible if the appropriate foundation is established. 10
]]>
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You
should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
